Skip to content

Study of the effect of Botulinum Toxin in the treatment of hyperhidrosis in Parkinson's disease

Study of the effect of Botulinum Toxin in the treatment of hyperhidrosis in Parkinson's disease

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250729066689N1
Enrollment
20
Registered
2025-08-05
Start date
2025-10-23
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hyperhidrosis. Condition 2: Parkinson. Secondary focal hyperhidrosis Parkinson's disease

Interventions

Intervention 1: Intervention group: Patients who take botulinum toxin injection from the Dysport brand with a total dose of 100 units are as follows: The Starch-Iodine test (or Minor's Test) and a sta

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Parkinson's disease Axillary or palmar Hyperhidrosis Hyperhidrosis over 6 month

Exclusion criteria

Exclusion criteria: Allergy to botulinum toxin HDSS 1,2 Generalized hyperhidrosis Primary focal hyperhidrosis

Design outcomes

Primary

MeasureTime frame
Hyperhidrosis in patients with Parkinson's disease. Timepoint: 2 weeks and 3 month later. Method of measurement: Minor's Test and questionnaire.;Differences in treatment methods in secondary hyperhidrosis. Timepoint: 2 weeks and 3 month later. Method of measurement: Minor's Test and questionnaire.;Quality of life in patients with Parkinson's disease. Timepoint: 2 weeks and 3 month later. Method of measurement: Minor's Test and questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad Amin Behzadpour

Shahid Beheshti University of Medical Sciences

dermatologist6@gmail.com+98 21 5541 9005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026